Daily News Podcast

Galectin-3: A post-MI prognostic biomarker for our times


 

Is galectin-3 a post-MI prognostic biomarker for out times?Also today, postmenopausal estrogen use is down since 2006, watching for substance abuse risks among reservists who have never been deployed, and do free meals for physicians affect opioid prescribing?

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Allergies linked to autism spectrum disorder in children
MDedge Rheumatology
Study finds widespread use of medications with depression as side effect
MDedge Rheumatology
Type 2 diabetes may promote Parkinson development
MDedge Rheumatology
FDA database reveals many rheumatic and musculoskeletal adverse events on immunotherapies
MDedge Rheumatology
TNF inhibitor linked to one-third drop in total mortality
MDedge Rheumatology
Routine AAA screening for older men: more harm than good?
MDedge Rheumatology
TNF inhibitor linked to one-third drop in total mortality
MDedge Rheumatology
Inflammatory myopathy following tattoo reported in an immunocompromised patient
MDedge Rheumatology
Impact of varicella vaccination on herpes zoster is not what was expected
MDedge Rheumatology
Canakinumab cut gout attacks in CANTOS
MDedge Rheumatology